Clinical Study

Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)

Table 9

Assessment of islet beta cell function and other simple insulin sensitivity indexes—mean ± SE ().

NGTHINSIGTT2DM

FINS5.29 ± 4.6111.69 ± 5.9811.87 ± 6.808.79 ± 6.590.029
FINS/FBG1.02 ± 0.752.37 ± 1.222.27 ± 1.341.15 ± 0.890.001
HOMA-IR0.99 ± 1.212.59 ± 1.382.78 ± 1.573.07 ± 2.290.006
QUICKI0.40 ± 0.050.34 ± 0.040.34 ± 0.030.34 ± 0.030.016
Matsuda index13.16 ± 7.244.86 ± 1.956.38 ± 3.756.24 ± 3.580.0005
Gutt index5.10 ± 1.293.62 ± 0.593.48 ± 0.0.802.77 ± 0.950.000
HOMA-β70.32 ± 32.43176.96 ± 115.28143.89 ± 93.4744.11 ± 35.500.000
Disposition index77.34 ± 34.5671.23 ± 29.4450.40 ± 19.6914.76 ± 7.070.000
Insulinogenic index69.02 ± 75.9499.26 ± 96.5815.68 ± 18.048.56 ± 7.200.000
value 0.005

Notes: differences among the four groups were compared using analysis of variance (ANOVA) or the Kruskal-Wallis test; the values were shown in the right column. Then we compare each parameter between any two patient groups, , compared with NGT, , compared with HINS, and , compared with IGT.